AG真人官方

Fiserv, Inc. (FI) has filed a Form 144 indicating the intention of Frank J. Bisignano to sell 10,542 common shares on or about 22 Jul 2025 through Morgan Stanley Smith Barney. The proposed sale carries an aggregate market value of $1.74 million based on the filing鈥檚 reference price and represents a negligible 0.002% of the company鈥檚 554.4 million shares outstanding.

Rule 144 requires disclosure of recent trading activity. The filing lists 鈮�2.62 million shares sold by Bisignano-affiliated accounts during the prior three months, generating 鈮�$457 million in gross proceeds. Individual transactions ranged from 1,122 shares to 250,000 shares, with frequent blocks of 100,000鈥�250,000 shares. The sales were executed on the NYSE and include a small call-option exercise.

No adverse non-public information is acknowledged, and the signatory affirms compliance with Rule 10b5-1 where applicable. While the upcoming 10,542-share sale is immaterial in isolation, the aggregate pace and value of recent insider disposals are noteworthy for investors monitoring insider sentiment and potential overhang.

Roivant Sciences Ltd. (ROIV) 鈥� Form 144 filing: Dr. Eric Venker has notified the SEC of his intent to sell up to 100,000 common shares through Rockefeller Financial beginning 21 Jul 2025. At the filing鈥檚 reference price, the block is valued at roughly $1.15 million and will trade on Nasdaq. Roivant lists 713.55 million shares outstanding, so the planned sale equals only 鈮�0.014 % of the float.

The notice also summarizes Venker鈥檚 recent activity: over the past three months he disposed of 1,082,835 shares across eight transactions, generating 鈮�$11.72 million in gross proceeds (20 Feb 鈥� 20 Jun 2025). The securities being sold were acquired via option exercise dated 20 Apr 2022 and paid for by wire.

No financial or operational metrics accompany the filing. From a capital-markets perspective, the proposed sale is immaterial to Roivant鈥檚 share count, yet the continuing insider sales trend can be interpreted as a modestly negative sentiment signal for investors.

On 22 Jul 2025 Classover Holdings, Inc. filed this Form 8-K/A to correct its 21 Jul 2025 report and add new disclosures. The company replaces an erroneously filed exhibit with the proper Equity Purchase Facility Agreement (EPFA) signed 30 Apr 2025 with Solana Strategic Holdings LLC, which allows Classover to sell up to $400 million in Class B shares. A 21 Jul 2025 amendment to the EPFA removes earlier restrictions on using sale proceeds to buy Solana tokens, giving management broader discretion but tying capital deployment more tightly to crypto-asset prices.

The filing also includes a waiver to the 6 Jun 2025 Registration Rights Agreement with Solana Growth Ventures LLC, extending the SEC registration filing deadline to 75 days (from 45) and the effectiveness deadline to 150 days (from 135). This eases near-term compliance pressure but delays potential resale liquidity for noteholders.

Under Item 7.01, Classover furnished a press release announcing the launch of its 鈥�KIDZ by Everstake鈥� Solana validator node, further illustrating the company鈥檚 strategic push into the Solana ecosystem. No earnings or balance-sheet data are provided.

Investor focus: enlarged share-issuance capacity, possible dilution, and increased exposure to crypto-market volatility following the relaxation of use-of-proceeds limits.

Form 4 insider filing 鈥� Fiserv, Inc. (FI)

On 30 June 2025, director Charlotte Yarkoni elected to defer US$32,500 of board fees under Fiserv鈥檚 Non-Employee Director Deferred Compensation Plan. In exchange, she received 189 deferred-compensation notional units, calculated at the same-day closing share price of $172.41. Each unit represents the right to receive one share of Fiserv common stock after her board tenure ends.

• Transaction code: A (acquisition, non-open-market)
• Units acquired: 189
• Implied value: $32,500
• Post-transaction holdings: 1,100 notional units (direct ownership)
• Settlement: 1-for-1 share conversion upon separation

The filing reports no sales, option exercises, or other derivative activity. Because the transaction stems from fee deferral rather than discretionary share purchases, it does not signal a valuation call, yet it marginally increases equity alignment between the director and shareholders. Given Fiserv鈥檚 multibillion-dollar market capitalisation, the dollar value is immaterial to earnings or valuation models and is unlikely to affect trading sentiment. Investors may view the steady use of the deferred-fee program as normal governance practice rather than a catalyst.

ZoomInfo Technologies Inc. (ZI) 鈥� Form 144 filing discloses a planned insider sale under Rule 144.

• Securities to be sold: 14,773 Class A common shares.
• Estimated market value: US$148,911.84 (based on prevailing market price cited in the form).
• Seller of record: James M. Roth, acting pursuant to a Rule 10b5-1 trading plan, with Morgan Stanley Smith Barney LLC as broker.
• Planned sale date: on or about 02 July 2025 through NASDAQ.
• Share-count context: ZI reports 328,911,200 shares outstanding; the proposed sale represents 鈮�0.0045 % of shares outstanding.
• Recent activity: The same insider sold 18,408 shares on 05 June 2025 for gross proceeds of US$184,398.72.

The filing is a routine notice rather than a completed transaction. Given the small size relative to total float, the event is unlikely to be materially impactful for shareholders, but it does provide visibility into insider trading activity and possible sentiment.

GitLab Inc. (NASDAQ: GTLB) has filed a Form 144 disclosing the proposed sale of 1,214 shares of its Class A common stock under Rule 144. The shares, valued at roughly $55,249, account for less than 0.001 % of the company鈥檚 approximately 146.1 million shares outstanding, making the transaction immaterial to GitLab鈥檚 overall float and market liquidity.

The seller acquired the stock as restricted stock units (RSUs) on 27 June 2025 and intends to execute the sale through Morgan Stanley Smith Barney LLC on or after 2 July 2025. No additional sales by this filer have occurred in the past three months. The notice states that the filer is unaware of any non-public adverse information, suggesting this is a routine liquidity event rather than a signal of strategic change.

Paymentus Holdings, Inc. (PAY) has filed a Form 4 disclosing that its Chairman, President & CEO, Dushyant Sharma, received 1,100,000 Class A RSUs on 07/02/2025 under the company鈥檚 2021 Equity Incentive Plan. Each RSU converts into one share of Class A common stock as it vests. Vesting schedule: one-sixteenth of the award will vest on each quarterly vesting date beginning 15 Aug 2025 (Feb 15, May 15, Aug 15, Nov 15 thereafter), subject to continued service. Following the grant, the reporting person shows 1,100,000 shares owned directly and an additional 1 share held indirectly through Ashigrace LLC, where Sharma holds sole voting and dispositive power. No price was paid for the RSUs, indicating a standard equity-based compensation grant designed to align executive incentives with shareholder value over time.

Paymentus Holdings, Inc. (PAY) has filed a Form 4 disclosing that its Chairman, President & CEO, Dushyant Sharma, received 1,100,000 Class A RSUs on 07/02/2025 under the company鈥檚 2021 Equity Incentive Plan. Each RSU converts into one share of Class A common stock as it vests. Vesting schedule: one-sixteenth of the award will vest on each quarterly vesting date beginning 15 Aug 2025 (Feb 15, May 15, Aug 15, Nov 15 thereafter), subject to continued service. Following the grant, the reporting person shows 1,100,000 shares owned directly and an additional 1 share held indirectly through Ashigrace LLC, where Sharma holds sole voting and dispositive power. No price was paid for the RSUs, indicating a standard equity-based compensation grant designed to align executive incentives with shareholder value over time.